[ad_1]
for vaccine available to all we will have to wait half 2021. Say it’s thewho after yesterday, the EU Commission announced that a vaccine for the highest risk categories (starting with health professionals) could be available from November. in the meantime The Lancet magazine has published the first data on the Russian Sputnik vaccine: as reported by Denis Logunov’s group, from the Gamaleya National Institute for Epidemiological Research in Moscow, the vaccine would have produced an immune response in the 76 volunteers, healthy adults between 18 and 60 years, involved in phases 1 and 2 of the trial. The results, referring to two studies conducted between June 18 and August 3, show that 100% of the participants developed antibodies against the SarsCov2 virus, without presenting serious side effects.
READ ALSO School and masks, the Cts: “They also work well on cloth”
“We do not expect to see widespread vaccination until the middle of next year,” WHO spokeswoman Margaret Harris said at a news conference on the coronavirus in Geneva, reported by The Guardian. “This phase 3 takes longer because we have to see how protective the vaccine really is and how safe it is,” he explained in reference to ongoing clinical trials.
ALSO READ Covid, the shock study: “In December up to 30 thousand deaths a day in the world”
Last updated: 21:11 © REPRODUCTION RESERVED
[ad_2]
